Home
Clinical Trials
Molecular Assessment of Drug ...

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

Last Updated: 2016-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1179 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Detection of the drug resistance molecular markers for falciparum and vivax in Longitudinal follow-up samples collected in Shwegyin Township, Bago Region that is Artemisinin Resistance Containment Tier I.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

NCT02792816

Drug Resistance Plasmodium Falciparum Malaria

COMPLETED

Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

NCT02198573

Day-3 Positive of Parasitaemia Prevalence of Drug Resistance Gene Mutation

COMPLETED

Drug Resistance Among Asymptomatic Infection

NCT03648411

Drug Resistant Malaria Asymptomatic Infections Migrant Workers

COMPLETED

Prevalence Survey of Antimalarial Drug Resistance Markers

NCT03217851

Malaria

COMPLETED

Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

NCT02974348

Drug Resistant Malaria Due to Plasmodium Falciparum

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is longitudinal and observational cohort study to detect the drug resistance molecular markers in asymptomatic malaria infected local residents in study site. Only local residence who are not migrants, are recruited in the study and active and passive surveillance have been carried out within one year observation period. At the time of enrollment, blood film examination, rapid diagnosis test (RDT) testing have been done all together with the collection of the venous blood (about 1-2 mL) that would be used for molecular analysis later. All of the RDT or microscopy positive cases were treated according to the National Malaria Treatment Policy in Myanmar. A total of at least 1000 participants have been recruited in the study. Active case detection has been done in every three months. The venous blood were used for molecular based detection of the asymptomatic malaria infection by using High-throughout pooling strategy. All of the positive samples, (falciparum and vivax), have been checked for drug resistance molecular analaysis compared with the previously collected symptomatic malaria infection cases in the same region.